Literature DB >> 30653964

The association of mitochondrial DNA haplogroups with POAG in African Americans.

Harini V Gudiseva1, Maxwell Pistilli1, Rebecca Salowe1, Larry N Singh2, David W Collins1, Brian Cole3, Jie He1, Sayaka Merriam1, Naira Khachataryan1, Jeffrey Henderer4, Victoria Addis1, Qi N Cui1, Prithvi S Sankar1, Eydie Miller-Ellis1, Venkata R M Chavali1, Gui-Shuang Ying1, Douglas Wallace2, Joan M O'Brien5.   

Abstract

Mitochondrial dysfunction has been implicated in the pathogenesis of primary open-angle glaucoma (POAG). However, the potential significance of mitochondrial DNA (mtDNA) haplogroups to POAG has not been evaluated in the overaffected African American population. To investigate the association of mtDNA haplogroups with POAG and its phenotypic characteristics, genotyping data from 4081 African American subjects (1919 cases and 2162 controls) was analyzed using 1293 positions on mtDNA. The overall frequency of mtDNA haplogroups in the Primary Open-Angle African American Glaucoma Genetics (POAAGG) study cohort was 37% L3, 29% L2, 21% L1, 4% L0, and 10% non-African haplogroups (non-L). When all haplogroups (L0, L1, L2, and non-L) were compared against theL3 reference group, after adjusting by age and principal component of ancestry, the non-L3 haplogroups showed higher risk of POAG (OR-1.19, p = 0.02), with a particularly strong association among males (OR = 1.41, p = 0.003). More specifically the non-L group was associated with higher POAG risk than the L3 haplogroup (OR = 1.77, p = 0.007, Bonferroni adjusted p = 0.027) and to the L3e (n = 256, OR = 1.92, p = 0.007, Bonferroni adjusted p = 0.029). No significant association was found when genders were analyzed together or in female only analysis. There were no significant differences in various POAG endophenotypes across mtDNA haplogroups. This study expands our knowledge of mitochondrial genetics and mtDNA haplogroup associations in African American POAG. Further work is needed to better understand the functional role of mtDNA polymorphisms and their interactions with nuclear genes that affect POAG.
Copyright © 2019 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  African Americans; Glaucoma; Mitochondrial genetics; Mitochondrial haplogroups; Primary open-angle glaucoma

Mesh:

Substances:

Year:  2019        PMID: 30653964      PMCID: PMC6443410          DOI: 10.1016/j.exer.2019.01.015

Source DB:  PubMed          Journal:  Exp Eye Res        ISSN: 0014-4835            Impact factor:   3.467


  38 in total

1.  Mitochondria and male disease.

Authors:  S A Frank; L D Hurst
Journal:  Nature       Date:  1996-09-19       Impact factor: 49.962

2.  Racial variations in the prevalence of primary open-angle glaucoma. The Baltimore Eye Survey.

Authors:  J M Tielsch; A Sommer; J Katz; R M Royall; H A Quigley; J Javitt
Journal:  JAMA       Date:  1991-07-17       Impact factor: 56.272

3.  Mother's curse neutralizes natural selection against a human genetic disease over three centuries.

Authors:  Emmanuel Milot; Claudia Moreau; Alain Gagnon; Alan A Cohen; Bernard Brais; Damian Labuda
Journal:  Nat Ecol Evol       Date:  2017-08-21       Impact factor: 15.460

4.  The primary open-angle african american glaucoma genetics study: baseline demographics.

Authors:  Emily S Charlson; Prithvi S Sankar; Eydie Miller-Ellis; Meredith Regina; Raymond Fertig; Julia Salinas; Maxwell Pistilli; Rebecca J Salowe; Allison L Rhodes; William T Merritt; Michael Chua; Benjamin T Trachtman; Harini V Gudiseva; David W Collins; Venkata Ramana Murthy Chavali; Charles Nichols; Jeffrey Henderer; Gui-Shuang Ying; Rohit Varma; Eric Jorgenson; Joan M O'Brien
Journal:  Ophthalmology       Date:  2015-01-08       Impact factor: 12.079

5.  Racial differences in the cause-specific prevalence of blindness in east Baltimore.

Authors:  A Sommer; J M Tielsch; J Katz; H A Quigley; J D Gottsch; J C Javitt; J F Martone; R M Royall; K A Witt; S Ezrine
Journal:  N Engl J Med       Date:  1991-11-14       Impact factor: 91.245

6.  The role of mitochondrial haplogroups in primary open angle glaucoma.

Authors:  R Andrews; T Ressiniotis; D M Turnbull; M Birch; S Keers; P F Chinnery; P G Griffiths
Journal:  Br J Ophthalmol       Date:  2006-04       Impact factor: 4.638

7.  Incompatibility between Nuclear and Mitochondrial Genomes Contributes to an Interspecies Reproductive Barrier.

Authors:  Hong Ma; Nuria Marti Gutierrez; Robert Morey; Crystal Van Dyken; Eunju Kang; Tomonari Hayama; Yeonmi Lee; Ying Li; Rebecca Tippner-Hedges; Don P Wolf; Louise C Laurent; Shoukhrat Mitalipov
Journal:  Cell Metab       Date:  2016-07-14       Impact factor: 27.287

8.  Mitochondrial DNA haplogroups confer differences in risk for age-related macular degeneration: a case control study.

Authors:  M Cristina Kenney; Dieter Hertzog; Garrick Chak; Shari R Atilano; Nikan Khatibi; Kyaw Soe; Andrew Nobe; Elizabeth Yang; Marilyn Chwa; Feilin Zhu; Masood Memarzadeh; Jacqueline King; Jonathan Langberg; Kent Small; Anthony B Nesburn; David S Boyer; Nitin Udar
Journal:  BMC Med Genet       Date:  2013-01-09       Impact factor: 2.103

9.  Mitochondrial Haplogroup Influences Motor Function in Long-Term HIV-1-Infected Individuals.

Authors:  Ashley Azar; Kathryn Devlin; Joshua Chang Mell; Tania Giovannetti; Vanessa Pirrone; Michael R Nonnemacher; Shendra Passic; Katherine Kercher; Jean W Williams; Jeffery M Jacobson; Brian Wigdahl; William Dampier; David J Libon; Christian Sell
Journal:  PLoS One       Date:  2016-10-06       Impact factor: 3.240

Review 10.  Global variations and time trends in the prevalence of primary open angle glaucoma (POAG): a systematic review and meta-analysis.

Authors:  Venediktos V Kapetanakis; Michelle P Y Chan; Paul J Foster; Derek G Cook; Christopher G Owen; Alicja R Rudnicka
Journal:  Br J Ophthalmol       Date:  2015-08-18       Impact factor: 4.638

View more
  1 in total

1.  WDR36-Associated Neurodegeneration: A Case Report Highlights Possible Mechanisms of Normal Tension Glaucoma.

Authors:  Elana Meer; Tomas S Aleman; Ahmara G Ross
Journal:  Genes (Basel)       Date:  2021-10-15       Impact factor: 4.096

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.